Click for best price
RadiopharmaceuticalsNuclear Medicine Market Size, Share 2022
Market Analysis and Insights: Global RadiopharmaceuticalsNuclear Medicine Market
The global RadiopharmaceuticalsNuclear Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RadiopharmaceuticalsNuclear Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RadiopharmaceuticalsNuclear Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RadiopharmaceuticalsNuclear Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RadiopharmaceuticalsNuclear Medicine market.
Global RadiopharmaceuticalsNuclear Medicine Scope and Market Size
Radiopharmaceuticals in Nuclear Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Segment by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
By Company
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes RadiopharmaceuticalsNuclear Medicine product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of RadiopharmaceuticalsNuclear Medicine, with price, sales, revenue, and global market share of RadiopharmaceuticalsNuclear Medicine from 2019 to 2022.
Chapter 3, the RadiopharmaceuticalsNuclear Medicine competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RadiopharmaceuticalsNuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the RadiopharmaceuticalsNuclear Medicine market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of RadiopharmaceuticalsNuclear Medicine.
Chapter 13, 14, and 15, to describe RadiopharmaceuticalsNuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 RadiopharmaceuticalsNuclear Medicine Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Radiopharmaceuticals in Nuclear Medicine Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
2.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Radiopharmaceuticals in Nuclear Medicine by Region (2023-2028)
2.5 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region
2.5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022)
2.5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.1 Global Top Radiopharmaceuticals in Nuclear Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medicine in 2021
3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers
3.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medicine Revenue in 2021
3.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type
4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022)
4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application
5.3.1 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2022)
5.3.2 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Type
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
6.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Application
6.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
6.2.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
6.3 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
6.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028)
6.3.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Type
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Application
7.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
7.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028)
7.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Type
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Application
8.2.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.3.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Type
9.1.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
9.1.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
9.2 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Application
9.2.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
9.2.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
9.3 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
9.3.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028)
9.3.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Type
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Application
10.2.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country
10.3.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Overview
11.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Imaging S.P.A. Recent Developments
11.2 Cambridge Isotope Laboratories, Inc.
11.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
11.2.2 Cambridge Isotope Laboratories, Inc. Overview
11.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cambridge Isotope Laboratories, Inc. Recent Developments
11.3 Cardinal Health, Inc.
11.3.1 Cardinal Health, Inc. Corporation Information
11.3.2 Cardinal Health, Inc. Overview
11.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cardinal Health, Inc. Recent Developments
11.4 Covidien, Plc
11.4.1 Covidien, Plc Corporation Information
11.4.2 Covidien, Plc Overview
11.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Covidien, Plc Recent Developments
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Corporation Information
11.5.2 Eczacibasi-Monrol Overview
11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eczacibasi-Monrol Recent Developments
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Corporation Information
11.6.2 Fujifilm Holdings Corporation Overview
11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fujifilm Holdings Corporation Recent Developments
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments
11.8 IBA Group
11.8.1 IBA Group Corporation Information
11.8.2 IBA Group Overview
11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IBA Group Recent Developments
11.9 Isotec, Inc. (Sigma-Aldrich)
11.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
11.9.2 Isotec, Inc. (Sigma-Aldrich) Overview
11.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Developments
11.10 Lantheus Medical Imaging, Inc.
11.10.1 Lantheus Medical Imaging, Inc. Corporation Information
11.10.2 Lantheus Medical Imaging, Inc. Overview
11.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lantheus Medical Imaging, Inc. Recent Developments
11.11 Nordion, Inc.
11.11.1 Nordion, Inc. Corporation Information
11.11.2 Nordion, Inc. Overview
11.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Nordion, Inc. Recent Developments
11.12 Ntp Radioisotopes (Pty), Ltd.
11.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
11.12.2 Ntp Radioisotopes (Pty), Ltd. Overview
11.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Developments
11.13 Siemens Healthcare (Subsidiary Of Siemens AG)
11.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
11.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Overview
11.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments
11.14 Taiyo Nippon Sanso Corporation
11.14.1 Taiyo Nippon Sanso Corporation Corporation Information
11.14.2 Taiyo Nippon Sanso Corporation Overview
11.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Taiyo Nippon Sanso Corporation Recent Developments
11.15 Urenco Limited
11.15.1 Urenco Limited Corporation Information
11.15.2 Urenco Limited Overview
11.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Urenco Limited Recent Developments
11.16 Rotem Industries, Ltd., Inc.
11.16.1 Rotem Industries, Ltd., Inc. Corporation Information
11.16.2 Rotem Industries, Ltd., Inc. Overview
11.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Rotem Industries, Ltd., Inc. Recent Developments
11.17 Australian Nuclear Association And Technology Organization (ANSTO)
11.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
11.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Overview
11.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments
11.18 Board of Radiation And Isotope Technology (BRIT)
11.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
11.18.2 Board of Radiation And Isotope Technology (BRIT) Overview
11.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Developments
11.19 Institute of Atomic Energy Polatom Radioisotope Centre
11.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
11.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Overview
11.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments
11.20 Institute of Isotopes Co., Ltd.
11.20.1 Institute of Isotopes Co., Ltd. Corporation Information
11.20.2 Institute of Isotopes Co., Ltd. Overview
11.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Institute of Isotopes Co., Ltd. Recent Developments
11.21 Institute Of Radioelement (IRE)
11.21.1 Institute Of Radioelement (IRE) Corporation Information
11.21.2 Institute Of Radioelement (IRE) Overview
11.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Institute Of Radioelement (IRE) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain Analysis
12.2 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceuticals in Nuclear Medicine Production Mode & Process
12.4 Radiopharmaceuticals in Nuclear Medicine Sales and Marketing
12.4.1 Radiopharmaceuticals in Nuclear Medicine Sales Channels
12.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors
12.5 Radiopharmaceuticals in Nuclear Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Radiopharmaceuticals in Nuclear Medicine Industry Trends
13.2 Radiopharmaceuticals in Nuclear Medicine Market Drivers
13.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges
13.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints
14 Key Findings in The Global Radiopharmaceuticals in Nuclear Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 3. Major Manufacturers of Therapy Radiopharmaceuticals
Table 4. Major Manufacturers of Enriched Stable Isotopes
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT)
Table 8. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2022)
Table 9. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT)
Table 10. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2023-2028)
Table 11. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2017-2022)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2023-2028)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2017-2022) & (K MT)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2017-2022)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2017-2022)
Table 19. Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers (2017-2022) &(USD/MT)
Table 20. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2021)
Table 22. Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Offered
Table 24. Date of Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 27. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2017-2022)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2023-2028)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2017-2022)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2023-2028)
Table 34. Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022) & (USD/MT)
Table 35. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2023-2028) & (USD/MT)
Table 36. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 37. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 38. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2017-2022)
Table 39. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2023-2028)
Table 40. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2017-2022)
Table 43. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2023-2028)
Table 44. Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2022) & (USD/MT)
Table 45. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2023-2028) & (USD/MT)
Table 46. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 47. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 48. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 51. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 52. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 55. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 56. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 59. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 60. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 63. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 64. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 67. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 68. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 71. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 72. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 75. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 76. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT)
Table 79. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT)
Table 80. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 83. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 84. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 87. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 88. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 91. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 92. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 95. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 96. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 99. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 100. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 103. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 104. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 106. Bracco Imaging S.P.A. Corporation Information
Table 107. Bracco Imaging S.P.A. Description and Major Businesses
Table 108. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 109. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Bracco Imaging S.P.A. Recent Developments
Table 111. Cambridge Isotope Laboratories, Inc. Corporation Information
Table 112. Cambridge Isotope Laboratories, Inc. Description and Major Businesses
Table 113. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 114. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Cambridge Isotope Laboratories, Inc. Recent Developments
Table 116. Cardinal Health, Inc. Corporation Information
Table 117. Cardinal Health, Inc. Description and Major Businesses
Table 118. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 119. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Cardinal Health, Inc. Recent Developments
Table 121. Covidien, Plc Corporation Information
Table 122. Covidien, Plc Description and Major Businesses
Table 123. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 124. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Covidien, Plc Recent Developments
Table 126. Eczacibasi-Monrol Corporation Information
Table 127. Eczacibasi-Monrol Description and Major Businesses
Table 128. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 129. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Eczacibasi-Monrol Recent Developments
Table 131. Fujifilm Holdings Corporation Corporation Information
Table 132. Fujifilm Holdings Corporation Description and Major Businesses
Table 133. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 134. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Fujifilm Holdings Corporation Recent Developments
Table 136. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 137. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 138. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 139. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments
Table 141. IBA Group Corporation Information
Table 142. IBA Group Description and Major Businesses
Table 143. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 144. IBA Group Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. IBA Group Recent Developments
Table 146. Isotec, Inc. (Sigma-Aldrich) Corporation Information
Table 147. Isotec, Inc. (Sigma-Aldrich) Description and Major Businesses
Table 148. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 149. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Isotec, Inc. (Sigma-Aldrich) Recent Developments
Table 151. Lantheus Medical Imaging, Inc. Corporation Information
Table 152. Lantheus Medical Imaging, Inc. Description and Major Businesses
Table 153. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 154. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Lantheus Medical Imaging, Inc. Recent Developments
Table 156. Nordion, Inc. Corporation Information
Table 157. Nordion, Inc. Description and Major Businesses
Table 158. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 159. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Nordion, Inc. Recent Developments
Table 161. Ntp Radioisotopes (Pty), Ltd. Corporation Information
Table 162. Ntp Radioisotopes (Pty), Ltd. Description and Major Businesses
Table 163. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 164. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Ntp Radioisotopes (Pty), Ltd. Recent Developments
Table 166. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
Table 167. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Major Businesses
Table 168. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 169. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments
Table 171. Taiyo Nippon Sanso Corporation Corporation Information
Table 172. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 173. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 174. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Taiyo Nippon Sanso Corporation Recent Developments
Table 176. Urenco Limited Corporation Information
Table 177. Urenco Limited Description and Major Businesses
Table 178. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 179. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Urenco Limited Recent Developments
Table 181. Rotem Industries, Ltd., Inc. Corporation Information
Table 182. Rotem Industries, Ltd., Inc. Description and Major Businesses
Table 183. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 184. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Rotem Industries, Ltd., Inc. Recent Developments
Table 186. Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
Table 187. Australian Nuclear Association And Technology Organization (ANSTO) Description and Major Businesses
Table 188. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 189. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments
Table 191. Board of Radiation And Isotope Technology (BRIT) Corporation Information
Table 192. Board of Radiation And Isotope Technology (BRIT) Description and Major Businesses
Table 193. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 194. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. Board of Radiation And Isotope Technology (BRIT) Recent Developments
Table 196. Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
Table 197. Institute of Atomic Energy Polatom Radioisotope Centre Description and Major Businesses
Table 198. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 199. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 200. Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments
Table 201. Institute of Isotopes Co., Ltd. Corporation Information
Table 202. Institute of Isotopes Co., Ltd. Description and Major Businesses
Table 203. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 204. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 205. Institute of Isotopes Co., Ltd. Recent Developments
Table 206. Institute Of Radioelement (IRE) Corporation Information
Table 207. Institute Of Radioelement (IRE) Description and Major Businesses
Table 208. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 209. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 210. Institute Of Radioelement (IRE) Recent Developments
Table 211. Key Raw Materials Lists
Table 212. Raw Materials Key Suppliers Lists
Table 213. Radiopharmaceuticals in Nuclear Medicine Distributors List
Table 214. Radiopharmaceuticals in Nuclear Medicine Customers List
Table 215. Radiopharmaceuticals in Nuclear Medicine Market Trends
Table 216. Radiopharmaceuticals in Nuclear Medicine Market Drivers
Table 217. Radiopharmaceuticals in Nuclear Medicine Market Challenges
Table 218. Radiopharmaceuticals in Nuclear Medicine Market Restraints
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medicine Product Picture
Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2021 & 2028
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2021 & 2028
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Other
Figure 12. Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Sales 2017-2028 (K MT)
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Revenue 2017-2028 (US$ Million)
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2022)
Figure 18. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2023-2028)
Figure 19. North America Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT)
Figure 20. North America Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT)
Figure 22. Europe Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT)
Figure 24. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT)
Figure 26. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT)
Figure 28. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Radiopharmaceuticals in Nuclear Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medicine in the World: Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2021
Figure 31. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028)
Figure 36. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 37. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
Figure 38. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 39. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028)
Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Sales Share by Country (2017-2028)
Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Revenue Share by Country (2017-2028)
Figure 42. U.S. Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
Figure 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 47. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028)
Figure 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Share by Country (2017-2028)
Figure 49. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share by Country (2017-2028)
Figure 50. Germany Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 51. France Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2017-2028)
Figure 61. China Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 64. India Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 72. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 74. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share
